Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Eniware
AddedFeb 15, 2024
UpdatedJun 18, 2026
Eniware

Eniware

Seed

Eniware: Power-independent, portable sterilization solutions globally, specializing in medical equipment.

HQ
Washington, D.C., DC, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in 2011, Eniware aims to revolutionize medical equipment sterilization with its portable, power-independent solutions. The company leverages Noxilizer, Inc.’s patented nitrogen dioxide (NO2) gas sterilization technology to offer safe and effective sterilization for surgical instruments, particularly in regions where electricity and water are unreliable or unavailable. Eniware’s mission is to enable essential surgeries globally, including in Africa, Asia, and the Middle East, as well as in military and disaster relief scenarios.

Eniware has secured exclusive licenses for its technology and is working towards FDA and CE approvals. The company has made significant strides in addressing global healthcare challenges by providing innovative sterilization solutions. Its impact is particularly notable in underserved regions, ensuring that safe surgical procedures can be performed even in the most resource-limited settings.

Eniware - Similar Companies

Noxilizer logo

Noxilizer

noxilizer.com

Sterifre Medical logo

Sterifre Medical

sterifre.com

SteriDev logo

SteriDev

steridev.com

Sterilucent logo

Sterilucent

sterilucent.com

NanoGuard Technologies logo

NanoGuard Technologies

Nevoa logo

Nevoa

nevoainc.com

Ideate Medical logo

Ideate Medical

ideatemedical.com

Tomi Environmental Solutions logo

Tomi Environmental Solutions

steramist.com

STERIS logo

STERIS

steris.com

Remedify logo

Remedify

remedify.com

SteriZign Precision Technologies logo

SteriZign Precision Technologies

sterizign.com

Sotera Health logo

Sotera Health

soterahealth.com

SurgiBox logo

SurgiBox

Helios Innovative Technologies logo

Helios Innovative Technologies

Medical Engineering Innovations logo

Medical Engineering Innovations

mei-america.com

Eniware - Quick Facts

Who are Eniware's competitors?

Companies similar to Eniware include Noxilizer, Sterifre Medical, SteriDev and Sterilucent.

When was Eniware founded?

Eniware was founded in 2011.

Where is Eniware's headquarters located?

Eniware's headquarters is located in Washington, D.C., DC, US.

When was Eniware's last funding round?

Eniware's most recent funding round was for $2.2M (USD) in March 2022.

How much has Eniware raised to-date?

As of Mar 17, 2022, Eniware has raised a total of $2.2M (USD).

How many employees does Eniware have?

Eniware has 7 employees as of Feb 5, 2024.

Eniware - Classification

Industry
  • Hardware
Technology
  • Technology
Geographic Exposure
  • Global
Revenue
  • Transactional
Main Product
  • Sterilization Medical
Tags
  • Enterprise Government
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified